Does Vitamin C Improve Endothelial Function? Reading Short-term and Long-term Evidence from an FMD Perspective

Does Vitamin C Improve Endothelial Function? Reading Short-term and Long-term Evidence from an FMD Perspective

January 4, 2026

Disclaimer (Important)

This article summarizes research findings and does not recommend specific intake. Please consult a healthcare professional if you have underlying conditions (such as kidney disease) or are taking medication.


TL;DR (Conclusion First)

  • Short-term (Single dose to hours): In conditions with “high oxidative stress” such as smoking or heart failure, there are trials showing endothelial function indicators (FMD/FDD, etc.) moving in an improving direction.
  • Long-term (Weeks+): While some trials show continued improvement, others show no sustained effect or no difference, and results vary by population and measurement method.
  • Overview (Meta-analysis): On average, it tends to improve. However, effects are significantly influenced by health status, dosage, administration route, and indicators.

Why look at “Endothelial Function”? (VascularEvidenceJapan Premise)

Endothelial function is the foundation regulating vascular tone, inflammation, and thrombotic tendency, centering on NO (nitric oxide). FMD (Flow-Mediated Dilation) and FDD (Flow-Dependent Dilation) are representative methods to peek into the “window of endothelial function” as a dilation response to increased blood flow (shear stress).


Representative Clinical Studies (Short-term / Long-term)

1) Smokers: Improvement in short term, but “not established” at 8 weeks

In young smokers, a single oral dose of 2g of Vitamin C improved FMD hours later, whereas 1g/day for 8 weeks showed no clear difference compared to placebo.

Key Point: Even if blood ascorbic acid levels rise, long-term endothelial response may not be determined by “antioxidant effect alone”.


2) Hypertension: Examples of no improvement in conduit vessel indicators (while some reports show improvement in resistance vessels)

In hypertensive patients, oral ascorbic acid treatment did not improve conduit vessel endothelial-dependent response.

On the other hand, there are reports that it improved in resistance vessel systems (forearm blood flow response, etc.) via antioxidant effects, and the effect was negated by NO inhibition.

  • Taddei S, et al. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension (Circulation, 1998) PubMed: https://pubmed.ncbi.nlm.nih.gov/9631871/

Key Point: Even for “endothelial function”, the conclusion changes depending on what was measured (conduit vs. resistance vessels, FMD/FDD/pharmacological tests).


3) Chronic Heart Failure: Example of improvement with acute + 4 weeks, verified up to NO involvement

In patients with chronic heart failure, Vitamin C improved FDD with both acute administration and 4 weeks of oral administration, and the “NO component” was confirmed by NO synthesis inhibition.

Key Point: Consistent with the hypothesis that short-term effects are more visible in “pathologies with strong oxidative stress”.


Overview: What do Meta-analyses say?

Systematic reviews/meta-analyses collecting randomized controlled trials summarize that Vitamin C supplementation moves endothelial function in an improving direction on average, and the effect is influenced by health status, duration of administration, dosage, and administration route.


References

  • Raitakari OT, et al. J Am Coll Cardiol. 2000.
  • Duffy SJ, et al. Am J Physiol Heart Circ Physiol. 2001.
  • Taddei S, et al. Circulation. 1998.
  • Hornig B, et al. Circulation. 1998.
  • Ashor AW, et al. Atherosclerosis. 2014.